Top Influenza Vaccine News of 2019

The Influenzer Initiative
3 min readJan 13, 2020

--

11 points of progress towards next-generation influenza vaccine development

1. EU — India joint call “Towards a Next Generation Influenza Vaccine to Protect Citizens Worldwide”

Delegation of the European Union to India and Bhutan / January 8, 2018

2. The Sabin Vaccine Institute Celebrates the Reintroduction of the Flu Vaccine Act

Mary Beth Woodin, Sabin Vaccine Institute / February 27, 2019

3. NIH begins first-in-human trial of a universal influenza vaccine candidate

Jennifer Routh, National Institutes of Health / April 3, 2019

4. Long-term studies will track indelible marks of first flu

Declan Butler, Nature News / May 14, 2019

5. Sabin Vaccine Institute and The Aspen Institute Release Report Calling for Bold, New, and Coordinated Commitments to Making Universal Influenza Vaccines a Reality

Sabin Vaccine Institute / July 25, 2019

6. With new grants, Gates Foundation takes an early step toward a universal flu vaccine

Helen Branswell, STAT / August 29, 2019

7. Mitigating the Impact of Pandemic Influenza through Vaccine Innovation

The U.S. Council of Economic Advisers / September 2019

8. Executive Order on Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health

The Executive Office of the President/ September 19, 2019

9. NIH Forms New Collaborative Influenza Vaccine Research Network

Elizabeth Deatrick, National Institute of Allergy and Infectious Diseases / September 30, 2019

10. Researchers bring us one step closer to universal influenza vaccine

The Mount Sinai Hospital, Medical Xpress / October 16, 2019

11. The Search for a Universal Flu Vaccine Heats Up

Jennifer Abbasi, Journal of the American Medical Association / November 6, 2019

--

--

The Influenzer Initiative
The Influenzer Initiative

Written by The Influenzer Initiative

Engaging and informing expertise from across research disciplines and industry sectors to drive innovation towards universal influenza vaccine development.

No responses yet